Chief Science Officer
AXON Neuroscience SE
Norbert Žilka Assoc. Prof, DVM, PhD, has been working for AXON Neuroscience since the foundation of the company in 1999. Norbert Žilka played a key role in AXON Neuroscience's leading discoveries, which he further helped to transform into AXON´s portfolio of products. In 2006 he gained a PhD. in Immunology under the supervision of Prof. Michal Novák. He has devoted 17 years of his life to the research of Alzheimer's disease and is the author of over 50 publications. Norbert Žilka, was previously responsible for creating novel animal models for human neurodegenerative disorders and preclinical development of AXON’s immunotherapeutics, as Head of preclinical studies. Using animal models, he identified molecular mechanism of interactions between brain immune system and disease modified protein tau. He is considered to be the author of the tau immunological cascade in Alzheimer’s disease. Norbert Žilka was a national coordinator of a project focused on the harmonization of biomarker measurement across Europe, Biomarkers for Alzheimer’s disease and Parkinson’s disease. He is the co-author of the Synaptic Dysfunction in Alzheimer’s Disease, a project funded by Marie Sklodowska-Curie Innovative Training Network and was a national coordinator and chairman of the Neuroscience session at the first Frontiers of Science Meeting organized by the Royal Society and V4 countries in 2010.